"Mitotic Slippage" and Extranuclear DNA in Cancer Chemoresistance: A Focus on Telomeres

Kristine Salmina1, Agnieszka Bojko2, Inna Inashkina1

  • 1Cancer Research Division, Latvian Biomedicine Research and Study Centre, LV-1067 Riga, Latvia.

Insights

TP53-mutant cancer cells undergoing mitotic slippage (MS) release damaged telomeres into the cytoplasm. These cells then use alternative lengthening of telomeres (ALT) and inverted meiosis (IM) to recover and restart cell division.

Area of Science:

  • Cell Biology
  • Genetics
  • Cancer Research

Background:

  • Mitotic slippage (MS) is a cellular response in TP53-mutant tumors resistant to genotoxic therapy, leading to a doubled genome.
  • Polyploid cells resulting from MS exhibit premature senescence and cytoplasmic DNA damage.
  • Doxorubicin (DOX) is a genotoxic agent used in cancer therapy.

Purpose of the Study:

  • To investigate the mechanisms of mitotic slippage (MS) in the MDA-MB-231 cell line treated with doxorubicin (DOX).
  • To understand how TP53-mutant cancer cells cope with DNA damage and polyploidy.
  • To explore the role of telomere maintenance and meiosis in cancer cell recovery.

Main Methods:

  • Treatment of MDA-MB-231 cells with doxorubicin (DOX).
  • Analysis of telomere fragments, DNA double-strand breaks (γH2AX), and associated proteins (hTERT, TRF2, SQSTM1/p62) in the cytoplasm.
  • Investigation of alternative lengthening of telomeres (ALT), homologous recombination (HR), and promyelocytic leukemia (PML) bodies.
  • Observation of meiotic gene activation, holocentric chromosomes, and inverted meiosis (IM).

Main Results:

  • Selective release of telomere fragments enriched in hTERT, TRF2, and γH2AX into the cytoplasm, associated with SQSTM1/p62.
  • Concomitant activation of ALT and HR within nuclear PML bodies.
  • Induction of meiotic genes and holocentric chromosomes, leading to inverted meiosis (IM) in repeated MS cycles.
  • Formation of giant, amoeboid cells that bud off depolyploidized progeny, restarting mitotic cycling.

Conclusions:

  • Mitotic slippage involves a reversible conversion from telomerase-based telomere maintenance to ALT, coupled with IM at sub-telomere breakage sites induced by SPO11.
  • These converging mechanisms at telomeres mimic an amoeba-like life cycle, reducing mutagenic load.
  • The process enables the recovery of recombined, reduced progeny for re-entry into the mitotic cycle, facilitating cancer cell survival and therapy resistance.

Related Concept Videos

Replication in Eukaryotes01:29

Replication in Eukaryotes

In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
16.7K
Replication in Eukaryotes02:31

Replication in Eukaryotes

Overview
201.8K
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
26.5K
Telomeres and Telomerase02:41

Telomeres and Telomerase

6.7K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K